12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Biomerica, Cingulate, Arcutis Biotherapeutics, Panbela Therapeutics, NRX Pharmaceuticals, and Alaunos Therapeutics saw their shares rise by 54.5%, 33.33%, 31.14%, 30.54%, 30.08%, and 29.89% respectively. Conversely, Minerva Surgical, Checkpoint Therapeutics, Structure Therapeutics, Lantheus Holdings, Ainos, and Blue Water Biotech faced declines of 52.5%, 50.31%, 45.24%, 18.8%, 18.08%, and 16.08% respectively.
December 19, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ainos' shares fell 18.08% to $2.72, with a market cap of $12.7 million.
Ainos' pre-market decline could signal a short-term downward trend as market participants react.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Blue Water Biotech's shares decreased by 16.08% to $0.2, with a market value of $3.7 million.
The pre-market decrease in Blue Water Biotech's shares may indicate a negative short-term outlook for the stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Checkpoint Therapeutics' shares declined by 50.31% to $1.65, with a market cap of $38.8 million.
The significant pre-market drop in Checkpoint Therapeutics' shares could foreshadow a short-term negative trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Structure Therapeutics' stock declined by 45.24% to $32.4, with a market value of $1.5 billion.
The large pre-market decline for Structure Therapeutics suggests a bearish outlook that may persist in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Lantheus Holdings' shares declined by 18.8% to $61.75, with a market value of $4.2 billion.
The pre-market drop in Lantheus Holdings' stock price may reflect short-term bearish sentiment among investors.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's stock decreased by 52.5% to $1.34, with a market cap of $11.8 million.
The sharp pre-market decline in Minerva Surgical's stock price indicates negative investor sentiment, likely leading to a short-term downtrend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Arcutis Biotherapeutics' shares increased by 31.14% to $3.2, with a market cap of $302.0 million.
The substantial pre-market rise for Arcutis Biotherapeutics may lead to a short-term bullish trend as investor interest grows.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Biomerica shares surged 54.5% in pre-market trading with a market cap of $25.7 million.
The significant pre-market increase in Biomerica's stock price suggests positive investor sentiment which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cingulate's stock rose by 33.33% to $2.84 with a market cap of $2.6 million.
Cingulate's notable pre-market gain indicates potential investor optimism, possibly driving short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NRX Pharmaceuticals' shares rose 30.08% to $0.44, with a market cap of $37.5 million.
The pre-market increase in NRX Pharmaceuticals' shares could suggest a short-term positive trend for the stock.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Panbela Therapeutics' stock increased by 30.54% to $0.6, with a market cap of $3.0 million.
Panbela Therapeutics' pre-market jump could indicate a short-term positive momentum for the stock.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Alaunos Therapeutics' stock moved upwards by 29.89% to $0.06, with a market cap of $14.2 million.
Alaunos Therapeutics' pre-market rise may lead to short-term positive price action as investors respond to the uptick.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100